Aquestive Therapeutics, Inc. (AQST) Revenue Growth
Aquestive Therapeutics, Inc. (AQST) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2019-12-31 | -21.98% |
| 2020-12-31 | -12.85% |
| 2021-12-31 | 10.87% |
| 2022-12-31 | -6.20% |
| 2023-12-31 | 6.09% |
| 2024-12-31 | 13.80% |
| 2025-12-31 | -22.61% |
How AQST compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | 12.87% |
| EOLS | Evolus Inc. | 11.61% |
| RDNT | RadNet Inc. | 11.51% |
| AGEN | Agenus Inc. | 10.37% |
| QTRX | Quanterix Corporation | 1.07% |
These are five companies in the same sector as AQST with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Aquestive Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("AQST", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AQST | $5.34 | -0.19% | 2.12M |
| 3 | ||||
| 4 | ||||
| 5 |